Equities analysts expect West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings per share of $0.53 for the current quarter, Zacks reports. Three analysts have provided estimates for West Pharmaceutical Services’ earnings, with the highest EPS estimate coming in at $0.54 and the lowest estimate coming in at $0.53. West Pharmaceutical Services also posted earnings per share of $0.53 during the same quarter last year. The company is scheduled to issue its next quarterly earnings report on Thursday, October 26th.

On average, analysts expect that West Pharmaceutical Services will report full-year earnings of $2.68 per share for the current financial year, with EPS estimates ranging from $2.66 to $2.69. For the next year, analysts forecast that the firm will post earnings of $2.89 per share, with EPS estimates ranging from $2.80 to $2.97. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for West Pharmaceutical Services.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The company had revenue of $397.60 million during the quarter, compared to analysts’ expectations of $406.00 million. During the same quarter in the previous year, the business earned $0.59 earnings per share. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis.

Several brokerages have recently commented on WST. Jefferies Group LLC upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $115.00 target price for the company in a research report on Friday. BidaskClub lowered West Pharmaceutical Services from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 price target on the stock in a report on Friday, June 9th. Two research analysts have rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $98.52.

Shares of West Pharmaceutical Services (NYSE WST) traded up 4.61% during midday trading on Friday, reaching $95.91. The company’s stock had a trading volume of 761,446 shares. The company’s 50-day moving average price is $87.31 and its 200 day moving average price is $89.20. The firm has a market capitalization of $7.10 billion, a PE ratio of 41.16 and a beta of 1.13. West Pharmaceutical Services has a 1-year low of $70.17 and a 1-year high of $99.91.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Investors of record on Wednesday, October 18th will be issued a $0.14 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Tuesday, October 17th. This represents a $0.56 annualized dividend and a dividend yield of 0.58%. West Pharmaceutical Services’s dividend payout ratio (DPR) is 22.22%.

A number of institutional investors have recently made changes to their positions in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of West Pharmaceutical Services by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,735 shares of the medical instruments supplier’s stock worth $1,015,000 after buying an additional 34 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in shares of West Pharmaceutical Services by 1.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after buying an additional 40 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of West Pharmaceutical Services by 0.7% in the 2nd quarter. Teacher Retirement System of Texas now owns 5,867 shares of the medical instruments supplier’s stock worth $555,000 after buying an additional 40 shares in the last quarter. Hillsdale Investment Management Inc. raised its stake in shares of West Pharmaceutical Services by 0.7% in the 2nd quarter. Hillsdale Investment Management Inc. now owns 12,080 shares of the medical instruments supplier’s stock worth $1,142,000 after buying an additional 80 shares in the last quarter. Finally, Private Advisor Group LLC raised its stake in shares of West Pharmaceutical Services by 3.2% in the 1st quarter. Private Advisor Group LLC now owns 2,899 shares of the medical instruments supplier’s stock worth $232,000 after buying an additional 91 shares in the last quarter. 91.25% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “$0.53 EPS Expected for West Pharmaceutical Services, Inc. (WST) This Quarter” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/15/0-53-eps-expected-for-west-pharmaceutical-services-inc-wst-this-quarter.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Get a free copy of the Zacks research report on West Pharmaceutical Services (WST)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.